Myeloid Disease with the CSF3R T618I Mutation after CLL
Chronic lymphocytic leukemia (CLL) is frequently an indolent diagnosis, with most of the patients being under surveillance for long time. There is an increased risk of a second neoplasia in CLL, rarely hematological (in the myeloid lineage is even rarer). A 58-year-old male was diagnosed with CLL in...
Saved in:
Main Authors: | Maria Eduarda Couto, Susana Bizarro, Domingos Sousa, Nelson Domingues, Isabel Oliveira, Gabriela Martins, Manuel R. Teixeira, Mário Mariz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2020/6670965 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of the CLL-1 protein in disease monitoring in patients diagnosed with acute myeloid leukaemia and myelodysplastic syndrome
by: Ewa Dobak, et al.
Published: (2024-10-01) -
Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation
by: Meng Zhang, et al.
Published: (2025-01-01) -
Modified CD15/CD16-CLL1 inhibitory CAR-T cells for mitigating granulocytopenia toxicities in the treatment of acute myeloid leukemia
by: Rui Zhang, et al.
Published: (2025-02-01) -
Philippe Descola, Par-delà nature et culture, Paris, Gallimard, 2006, 618 p.
by: Stéphane Callens
Published: (2006-09-01) -
Insights into CSF-1/CSF-1R signaling: the role of macrophage in radiotherapy
by: Qingchao Shang, et al.
Published: (2025-02-01)